Valid Insight are delighted to announce that we are joining the Bioscript group. Valid Insight will be the latest addition to the Bioscript Group as they extend their services in global market access consulting and payer value communications. We are looking forward to the exciting journey ahead and to building our partnership with Bioscript. Valid […]
In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry. With […]
At Valid Insight, we’re pleased to announce that in May 2020, we’ll be providing a series of specialist Market Access lectures as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a leading French graduate business school. Thanks to our TRAVELLESS™ solution, our trusted virtual platform that we […]
From years of experience in market access and the pharmaceutical industry, to our trusted client partnerships, we share our insights into what we believe has led to the team’s success and growth over the years.
Valid Insight’s Senior Executive Advisor, Raf De Wilde, has over 40 years’ experience in the pharmaceutical industry and over 30 years’ experience in global market access. Watch our video as he shares his expert insights in pharmaceutical pricing and market access:
Take a look at the very moment that one of the most esteemed business awards, the Queen’s Award for Enterprise in International Trade 2019, was presented to our team.
In October 2019, Valid Insight received the Queen’s Award for Enterprise in International Trade – recognised globally as one of the highest accolades for business success. Our video captures the best moments from the award ceremony. Watch it here:
In April this year, Valid Insight were awarded the Queen’s Award for Enterprise in International Trade 2019 – the UK’s most esteemed business award, given only to those companies who have demonstrated outstanding results in their field and achieved significant growth and success over three years. Winning this award is invaluable to our team and […]
In April, it was announced that the Valid Insight team had been awarded the Queen’s Award for Enterprise in International Trade. It was an amazing moment for us all. It was not only a testament to the team’s hard work and indisputable expertise, but to our clients’ trust in us to help them to keep […]
As part of our corporate responsibility to bring new talent in to the industry, our Senior Executive Advisor, Raf De Wilde, will be returning to the University of Duisburg-Essen to deliver a one-day masterclass on patient-reported outcomes and real-world evidence for students studying a Master of Science (MSc) in Pharmaceutical Medicine. We look forward to […]
The second edition of the medical writing in HEOR/Market Access careers guide was launched in June 2019. This guide focuses on medical writing roles in the HEOR/market access arenas, but will be of interest to anyone who wants to understand more about the business of ensuring access to new medicines and devices for patients. If you have […]
The Queen’s Awards for Enterprise are the UK’s most esteemed business awards, presented only to the most eminent of companies or individuals, demonstrating outstanding results in their field. Today, Her Majesty the Queen announced approval of the Prime Minister’s recommendation for Valid Insight to be honoured in recognition of the outstanding success of the company’s […]
Leukaemia is the 12th most common cancer in Europe, and the 11th most common worldwide. Leuka is a specialist leukaemia charity (now part of Leukaemia UK), investing in the next generation of leukaemia research talent in the UK and beyond. In 2017, Leuka raised nearly £1 million for research, and awarded £2.2 million to blood […]
Valid Insight, a specialist global market access consultancy firm with Europe based staff, including London, Belgium and Scotland, has joined the Scottish Lifesciences Association, in order to develop its role in life sciences in the region’s hubs, and to support the fast-growing local industry. “SLA is the voice of Scotland’s vibrant life sciences industries to […]
Valid Insight, the specialist global market access consultancy, are excited to announce that we have appointed Frank Cousins as Senior Director. Frank has over 20 years’ experience as a consultant to the pharmaceutical industry, specialising in the integration of regulatory strategy, evidence generation and market access for optimal launch and commercial planning. Frank Cousins will […]
As a rapidly growing pharma market access consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about market access, with demonstrable knowledge and experience in delivering international projects that make a difference, we’d love to hear from you. To learn more about what we […]
LONDON, UK – Just 18 months after its February 2016 launch, market access consultancy Valid Insight is pleased to announce the appointment of two new senior people to its rapidly expanding team. Dominic Jones-Phillips and James Wright bring decades of specialist experience from industry. Dominic Jones-Phillips and James Wright will lead global pricing, reimbursement, and […]
Current vacancies: Director, Market Access & Pricing Principal Consultant, Market Access & Pricing Senior Market Access & Payer Research Consultant Location: Europe-wide As a rapidly growing Pharma Market Access Consultancy, Valid Insight are looking for high calibre senior individuals to join us on our journey. If you are passionate about Market Access, with demonstrable knowledge […]
Dr Steve Bradshaw, leading a team of key life science advisors and market access experts, has launched Valid Insight, a new market access consultancy created to help companies navigate the challenges faced by drug developers seeking market access for new and innovative therapeutics. Getting a new drug to market and to patients who need better medicines […]